Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

AZN

Astrazeneca plc ADR

Last Close
May 23 • 04:00PM ET
78.18
Dollar change
-0.62
Percentage change
-0.79 		%
Scroll to Statements
IndexNDX P/E38.53 EPS (ttm)2.03 Insider Own0.02% Shs Outstand3.10B Perf Week1.48%
Market Cap242.40B Forward P/E16.68 EPS next Y4.69 Insider Trans0.00% Shs Float3.10B Perf Month9.80%
Income6.33B PEG2.85 EPS next Q1.01 Inst Own16.04% Short Float0.28% Perf Quarter18.76%
Sales47.61B P/S5.09 EPS this Y12.17% Inst Trans-2.07% Short Ratio1.59 Perf Half Y21.62%
Book/sh12.63 P/B6.19 EPS next Y15.11% ROA6.36% Short Interest8.53M Perf Year5.55%
Cash/sh2.59 P/C30.22 EPS next 5Y13.50% ROE17.29% 52W Range60.47 - 79.25 Perf YTD16.08%
Dividend Est.1.55 (1.98%) P/FCF28.58 EPS past 5Y17.72% ROI9.64% 52W High-1.35% Beta0.50
Dividend TTM1.45 (1.85%) Quick Ratio0.70 Sales past 5Y16.24% Gross Margin73.81% 52W Low29.29% ATR (14)0.98
Dividend Ex-DateFeb 22, 2024 Current Ratio0.89 EPS Y/Y TTM34.54% Oper. Margin17.50% RSI (14)69.38 Volatility1.15% 1.05%
Employees89900 Debt/Eq0.92 Sales Y/Y TTM8.60% Profit Margin13.30% Recom1.66 Target Price83.83
Option/ShortYes / Yes LT Debt/Eq0.75 EPS Q/Q20.85% Payout73.87% Rel Volume0.65 Prev Close78.80
Sales Surprise7.47% EPS Surprise7.80% Sales Q/Q16.55% EarningsApr 25 BMO Avg Volume5.36M Price78.18
SMA201.90% SMA509.60% SMA20015.82% Trades Volume3,477,331 Change-0.79%
Date Action Analyst Rating Change Price Target Change
Apr-16-24Upgrade Deutsche Bank Sell → Hold
Feb-08-24Downgrade Deutsche Bank Hold → Sell
Jan-23-24Initiated Morgan Stanley Overweight $85
Jan-16-24Resumed UBS Sell
Jan-03-24Downgrade Jefferies Buy → Hold $78.50 → $70
Dec-18-23Initiated HSBC Securities Buy $78
Sep-25-23Upgrade Jefferies Hold → Buy $66.50 → $80
Jul-14-23Initiated HSBC Securities Buy
Jul-12-23Upgrade UBS Neutral → Buy
Jul-05-23Downgrade Deutsche Bank Buy → Hold
Show Previous Ratings
May-23-24 02:53PM
Tango Therapeutics Shuts Early-Stage Cancer Study Due To Liver Toxicity
(Benzinga)
11:51AM
Pancreatic Cancer Battle Intensifies: Biotech Innovations Aim to Boost Survival Rates
(PR Newswire)
08:54AM
AstraZeneca and Nona Biosciences sign agreement for monoclonal antibody
(Pharmaceutical Technology)
07:00AM
AstraZeneca demonstrates commitment to patients living with amyloidosis at the 2024 International Symposium on Amyloidosis (ISA)
(Business Wire)
05:59AM
AstraZeneca pays $19M to Harbour BioMed's Nona for preclinical cancer antibodies
(FierceBiotech.com)
07:23PM Loading…
May-22-24 07:23PM
Nona Biosciences Announces Global License and Option Agreement with AstraZeneca for Monoclonal Antibody to be Developed into Novel Tumor Targeted Therapies
(PR Newswire)
05:17PM
Top 20 Largest Publicly Traded Healthcare Companies
(Insider Monkey)
11:45AM
Why Astrazeneca (AZN) is a Great Dividend Stock Right Now
(Zacks)
09:40AM
AstraZeneca joins obesity biotech SixPeaks at basecamp with $80M for buyout option
(FierceBiotech.com)
07:00AM
AstraZeneca furthers ambition to transform outcomes in early lung cancer and redefine metastatic breast cancer treatment at ASCO 2024
(Business Wire)
06:58AM
AstraZeneca targets $80bn revenue by 2030
(Pharmaceutical Business Review)
05:34AM
SixPeaks, a new obesity biotech, starts up with an option to sell to AstraZeneca
(BioPharma Dive)
May-21-24 05:41PM
AstraZeneca Rises to Record High After Announcing Plans for 'New Era of Growth'
(Investopedia)
04:27PM
Analyst Report: AstraZeneca PLC
(Morningstar Research)
01:45PM
AstraZenecas $80B sales plan leans on cancer drug expansion
(BioPharma Dive)
12:32PM Loading…
12:32PM
AstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030
(Zacks)
12:15PM
European Equities Close Lower in Tuesday Trading; AstraZeneca Targets $80 Billion in Revenue by 2030
(MT Newswires)
10:13AM
AstraZeneca aims increase its annual revenue by 75% in its post-COVID era
(Quartz)
09:10AM
Sector Update: Health Care Stocks Steady Premarket Tuesday
(MT Newswires)
08:24AM
AstraZeneca sets sights on $80B in revenue by 2030
(BioPharma Dive)
08:13AM
AstraZeneca to harness China's 'explosion' of innovation to boost cell therapy R&D
(FierceBiotech.com)
08:08AM
Compugen Ltd. (NASDAQ:CGEN) Q1 2024 Earnings Call Transcript
(Insider Monkey)
08:00AM
Midday movers: Microsoft, Xpeng rise; Palo Alto, Keysight fall
(Investing.com)
07:48AM
Health Care Roundup: Market Talk
(The Wall Street Journal)
04:21AM
AstraZeneca Targets $80 Billion Revenue by 2030, Expects to Launch 20 New Medicines
(MT Newswires)
04:01AM
AstraZeneca to establish $1.5bn ADC production site in Singapore
(Pharmaceutical Technology)
03:51AM
AstraZenecas Revenue Target Signals Pipeline Momentum
(The Wall Street Journal)
03:17AM
AstraZeneca Targets $80 Billion Revenue by 2030 Through Pipeline Expansion
(The Wall Street Journal)
03:15AM
AstraZeneca shares rise as pharma group unveils 2030 revenue target
(Investing.com)
02:14AM
AstraZeneca aims for $80 billion in total revenue by 2030
(Reuters)
02:00AM Loading…
02:00AM
AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post 2030
(Business Wire)
May-20-24 11:25PM
European stocks fall on Fed rate concerns; AstraZeneca lifts revenue target
(Investing.com)
04:38PM
Amgen/AstraZeneca Say Asthma Drug Shows Activity In Another Lung Disease Across Broad Patient Population
(Benzinga)
04:18PM
Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute
(Benzinga)
10:45AM
AstraZeneca (AZN) to Build $1.5B Cancer Drug Plant in Singapore
(Zacks)
06:47AM
Amgen and AstraZeneca's Lung Disease Drug Study Reports Mixed Results
(MT Newswires)
05:21AM
AstraZeneca to build $1.5bn ADCs facility in Singapore
(Investment Monitor)
04:22AM
Pfizer wins cancer drug patent case against AstraZeneca
(Pharmaceutical Technology)
04:11AM
AstraZeneca to Build $1.5 Billion Cancer Therapy Manufacturing Facility in Singapore
(MT Newswires)
02:49AM
AstraZeneca Plans $1.5 Billion Manufacturing Facility In Singapore
(The Wall Street Journal)
May-19-24 05:17PM
New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease
(Business Wire)
May-18-24 08:06AM
Flora Growth Corp. (NASDAQ:FLGC) Q1 2024 Earnings Call Transcript
(Insider Monkey)
May-17-24 04:12PM
Google DeepMind CEO: 'This Is the Next $100 Billion AI Business'
(InvestorPlace)
08:10AM
AIM ImmunoTech Inc. (AMEX:AIM) Q1 2024 Earnings Call Transcript
(Insider Monkey)
04:42AM
AstraZenecas Phase III Covid-19 antibody trial meets primary endpoints
(Clinical Trials Arena)
May-16-24 01:34PM
AstraZeneca's COVID-19 Prevention Therapy Cuts Risk Of Infection In Patients With Weaker Immunity, Data Shows
(Benzinga)
01:12PM
AstraZeneca's Sipavibart Prevents COVID-19 in Immunocompromised Patients in Phase 3 Trial
(MT Newswires)
10:51AM
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
(Benzinga)
07:17AM
AstraZeneca prepares fresh COVID push to regulators after antibody's phase 3 success
(FierceBiotech.com)
07:15AM
7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs
(InvestorPlace)
06:22AM
AstraZeneca selects new heart failure target with BenevolentAI
(Pharmaceutical Technology)
06:10AM
7 Blue-Chip Stocks to Protect Your Wealth as the Economy Slows
(InvestorPlace)
May-13-24 11:00PM
PRESS DIGEST-British Business - May 14
(Reuters)
02:07PM
UK pharma giants pledge £430m investment in France after Macron charm offensive
(The Telegraph)
01:35PM
Update: AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study
(MT Newswires)
12:43PM
AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study
(MT Newswires)
12:22PM
SOPHiA GENETICS SA (NASDAQ:SOPH) Q1 2024 Earnings Call Transcript
(Insider Monkey)
10:44AM
Invivyd, Inc. (NASDAQ:IVVD) Q1 2024 Earnings Call Transcript
(Insider Monkey)
10:30AM
France Secures $16 Billion From Microsoft, Amazon and Others at Foreign Investment Summit
(The Wall Street Journal)
07:37AM
Pfizer, AstraZeneca, Morgan Stanley Pledge Investments, Jobs to France
(MT Newswires)
12:45AM
UPDATE 3-'Choose France' investment push bags record $16 billion in pledges
(Reuters)
May-12-24 08:28AM
Pfizer and AstraZeneca announce new investments of nearly $1 billion in France
(Reuters)
08:25AM
UPDATE 1-Pfizer and AstraZeneca announce new investments of nearly $1 billion in France
(Reuters)
08:20AM
Forget Johnson & Johnson: Buy This Better Healthcare Stock Instead
(Motley Fool)
May-10-24 09:45AM
Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term
(Zacks)
09:30AM
Catalyst's New CEO Has Big Ideas For The Small Biotech
(Investor's Business Daily)
06:30AM
3 Biotech Stocks to Sell in May Before They Crash & Burn
(InvestorPlace)
May-09-24 03:48PM
Arcus Biosciences, Inc. (NYSE:RCUS) Q1 2024 Earnings Call Transcript
(Insider Monkey)
12:31PM
Personalis, Inc. (NASDAQ:PSNL) Q1 2024 Earnings Call Transcript
(Insider Monkey)
10:26AM
Biotech Innovations Surge as Global Cancer Diagnosis Rates Continue to Climb
(PR Newswire)
May-08-24 04:28PM
Update: AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents
(MT Newswires)
04:08PM
AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents
(MT Newswires)
03:15PM
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q1 2024 Earnings Call Transcript
(Insider Monkey)
02:07PM
AstraZeneca, Merck Sue Over Alleged Cancer Drug Patents Infringement
(MT Newswires)
01:30PM
AstraZenca is pulling its COVID vaccine
(Quartz)
01:06PM
Every household should be forced to have a smart meter, says British Gas boss
(The Telegraph)
11:47AM
AstraZeneca withdraws Covid-19 vaccine, citing low demand
(CNN Business)
09:04AM
AstraZeneca to Reportedly Withdraw COVID-19 Vaccine Amid Cooling Demand
(MT Newswires)
08:30AM
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Billion in 2024
(GlobeNewswire)
08:12AM
AstraZeneca withdraws COVID-19 vaccine, citing declining demand
(BioPharma Dive)
06:02AM
AstraZeneca to withdraw Covid-19 vaccine globally
(Pharmaceutical Technology)
06:00AM
7 Stocks to Buy Before the Next 'Great Reset' Begins in 2024
(InvestorPlace)
05:20AM
Q1 2024 Ionis Pharmaceuticals Inc Earnings Call
(Thomson Reuters StreetEvents)
May-07-24 11:12PM
PRESS DIGEST-British Business - May 8
(Reuters)
05:03PM
UPDATE 3-AstraZeneca to withdraw COVID vaccine globally as demand dips
(Reuters)
10:15AM
FibroGen, Inc. (NASDAQ:FGEN) Q1 2024 Earnings Call Transcript
(Insider Monkey)
08:57AM
Q1 2024 FibroGen Inc Earnings Call
(Thomson Reuters StreetEvents)
04:31AM
AstraZeneca concludes equity investment in Cellectis
(Pharmaceutical Technology)
May-06-24 02:06PM
How the Medical Industry Could Produce the Biggest AI Stock Winners
(InvestorPlace)
11:45AM
Why Astrazeneca (AZN) is a Top Dividend Stock for Your Portfolio
(Zacks)
07:58AM
AstraZeneca ups stake in Cellectis in latest cell therapy bet
(BioPharma Dive)
04:22AM
Cellectis Secures $140 Million Additional Equity Investment From AstraZeneca
(MT Newswires)
02:00AM
Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
(GlobeNewswire)
May-04-24 07:38AM
23 Most Profitable Stocks of the Last 12 Months
(Insider Monkey)
May-03-24 12:15PM
Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032
(PR Newswire)
04:21AM
AstraZeneca reports positive interim data from mantle cell lymphoma trial
(Clinical Trials Arena)
02:00AM
Angle PLC Announces New Commercial Agreement with Large Pharma
(ACCESSWIRE)
May-02-24 03:29PM
Boston Properties, Inc. (NYSE:BXP) Q1 2024 Earnings Call Transcript
(Insider Monkey)
11:02AM
AstraZeneca Says Calquence Combination Improves Progression-Free Survival in Phase 3 Mantle Cell Lymphoma Trial
(MT Newswires)
07:00AM
CALQUENCE combination regimen demonstrated statistically significant and clinically meaningful improvement in progression-free survival in 1st-line mantle cell lymphoma in ECHO Phase III trial
(Business Wire)
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.